Challenges and opportunities identifying therapeutic targets for chemotherapy-induced peripheral neuropathy resulting from oxidative DNA damage

Challenges and opportunities identifying therapeutic targets for chemotherapy-induced peripheral neuropathy resulting from oxidative DNA damage

Background on chemotherapy-induced peripheral neuropathy（CIPN）Incidence,prevalence,and consequences：Up to 90%of cancer patients experience CIPN at some point during or after anticancer treatment（Seretny et al.,2014）.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neural regeneration research 2017, Vol.12 (1), p.72-74
Hauptverfasser: Kelley, Mark, Fehrenbacher, Jill
Format: Artikel
Sprache:eng
Schlagworte:
Cancer patients
Cancer therapies
Care and treatment
Chemotherapy
Clinical trials
Complications and side effects
Deoxyribonucleic acid
Diagnosis
DNA
DNA damage
DNA repair
Drug dosages
Health aspects
Pain
Patients
Peripheral neuropathy
Polyneuropathies
Prevention
Risk factors
化疗
周围神经
氧化损伤
治疗
病变
癌症患者
识别
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background on chemotherapy-induced peripheral neuropathy（CIPN）Incidence,prevalence,and consequences：Up to 90%of cancer patients experience CIPN at some point during or after anticancer treatment（Seretny et al.,2014）.
ISSN:1673-5374
1876-7958
DOI:10.4103/1673-5374.198986